什么时候使用干细胞移植用于经典霍奇金淋巴瘤
Miguel-Angel Perales1,2, Sairah Ahmed3
1Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
新型疗法已经推进了霍奇金淋巴瘤 (HL) 治疗,减少了对干细胞移植的需求. 然而,对于正在进展或对检查点抑制剂疗法不耐受的患者来说,全基性HCT仍然是一个治愈的选择.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 霍奇金淋巴瘤 (HL) 是一种罕见的双模发病率的癌症,影响年轻人和老年人.
- 传统的治疗方法,如化疗和放射治疗,可以治愈大多数HL患者.
- 新型疗法,包括布伦图西马布维多丁和检查点抑制剂 (CPI),已经改变了HL的管理.
研究的目的:
- 审查干细胞移植 (SCT) 在霍奇金淋巴瘤中不断变化的作用.
- 要突出最近的数据支持在特定患者群体中全源造血细胞移植 (HCT).
主要方法:
- 文献综述,重点关注HL治疗的最新进展.
- 对使用新疗法和SCT的数据进行分析.
- 在CPI耐药/不耐受HL患者中对异构HCT结果的评估.
主要成果:
- 新型疗法导致在HL治疗中减少了自主和异性HCT的使用.
- 检查点抑制剂 (nivolumab, pembrolizumab) 越来越多地使用.
- 全基性HCT显示出作为耐火/不耐受病例的治疗策略的前景.
结论:
- 霍奇金淋巴瘤的治疗环境随着新药的出现而发生了重大变化.
- 虽然HCT的利用率有所下降,但全基性HCT仍然是高级或耐火性HL患者选择的关键治疗选择.
相关概念视频
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K


